Global Lancet And Pen Needles Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Insulin , Capillary Blood Sampling, Hormones , Glucose Like Peptide and Skin Testing.By Length;
4mm, 5mm, 6mm, 8mm, 10mm and 12mm.By Therapy;
Insulin, GLP-1, Growth, Hormone Therapy, Glucose Like Peptide (GLP) and Skin Testing.By Gauge;
17/18G, 21G, 23G, 25G, 28G and 30G.By End User;
Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, and Research & Academic Laboratories.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Lancet And Pen Needles Market (USD Million), 2021 - 2031
In the year 2024, the Global Lancet And Pen Needles Market was valued at USD 6,805.23 million. The size of this market is expected to increase to USD 11,968.72 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.
The global lancet and pen needles market serves as a vital component of the healthcare industry, providing essential tools for various medical procedures and diagnostic tests. Lancets and pen needles are indispensable for patients managing conditions like diabetes, requiring regular blood glucose monitoring and insulin administration. This market encompasses a diverse range of products segmented by type, including insulin needles, capillary blood sampling needles, hormone needles, glucose-like peptide needles, and skin testing needles. Each type caters to specific medical needs, reflecting the market's versatility and importance in supporting patient care and disease management worldwide.
The end-user landscape of the lancet and pen needles market is equally diverse, spanning hospitals, clinics, diagnostic centers, medical institutions, home care settings, and research laboratories. These end users rely on lancet and pen needles for a multitude of purposes, from routine blood glucose monitoring in clinical settings to self-administration of medication in the comfort of patients' homes.
Research institutions utilize these tools for experimental studies and medical research, highlighting the market's significance across various healthcare sectors. As the global healthcare landscape continues to evolve, driven by factors such as technological advancements, demographic shifts, and increasing awareness of preventive care, the demand for lancet and pen needles is expected to rise, presenting lucrative opportunities for manufacturers, suppliers, and stakeholders in the market.
Global Lancet And Pen Needles Market Recent Developments
-
In February 2023, Montmed, Inc. (Canada) announced issuance of a second US Patent for Sitesmart Pen Needles.
-
In April 2022, Embecta Corp. (US) completed the spin-off from Becton, Dickinson and Company (US) and started operating globally as a standalone pure-play diabetes care company.
Segment Analysis
The Global Lancet and Pen Needles Market has been segmented by Type, Length, Therapy, Gauge, and End User.
The Type segment includes Safety Lancets and Standard Lancets. Safety lancets have gained significant popularity due to their ability to minimize the risk of needlestick injuries. These lancets are designed with safety mechanisms that automatically retract the needle after use, making them a preferred option for healthcare settings and at-home use. On the other hand, standard lancets, while more commonly used in traditional settings, are less safe compared to safety lancets. The growing emphasis on patient safety and reducing accidental injuries is driving the demand for safety lancets, especially in hospitals and clinics.
The Length segment focuses on lancet needles of various sizes to cater to different patient needs. The length of lancet needles plays an important role in how effectively they can pierce the skin for blood collection or injections. Shorter needles are often preferred for less invasive procedures, while longer needles may be used in cases requiring deeper penetration. The choice of needle length is largely influenced by the therapeutic requirements and the patient's skin type, which leads to a growing variety of options in the market.
The Therapy segment includes Diabetes Management, Blood Collection, Insulin Administration, and other medical therapies. Diabetes management is one of the largest segments, driven by the increasing prevalence of diabetes worldwide. Lancets and pen needles are commonly used for insulin administration in diabetes patients, requiring regular monitoring of blood glucose levels. Blood collection, on the other hand, is critical for diagnostic purposes and is a growing area for lancet needles. The demand for lancet devices in insulin administration is expected to continue growing as the prevalence of diabetes increases globally.
The Gauge segment includes different needle gauges, such as 28G, 30G, 31G, etc. Needle gauge refers to the thickness of the needle, with smaller gauges indicating thicker needles and larger gauges corresponding to thinner needles. The selection of the gauge is based on patient comfort, the type of therapy, and the medical procedure. Thinner needles (higher gauge numbers) are generally preferred for more comfortable injections, which is crucial for patients with chronic conditions requiring frequent use of lancet devices.
Finally, the End User segment includes Hospitals, Clinics, Homecare, and Others. Homecare is one of the fastest-growing segments due to the increasing adoption of self-monitoring and self-injection devices for chronic diseases such as diabetes. Hospitals and clinics remain significant end users, where lancet devices are used in a variety of medical procedures. The increasing patient preference for at-home treatments is fueling the growth of the homecare segment, with a rise in the availability of lancet and pen needle products for personal use.
Global Lancet And Pen Needles Segment Analysis
In this report, the Global Lancet And Pen Needles Market has been segmented by Type, Length, Therapy, Gauge, End User, and Geography.
Global Lancet And Pen Needles Market, Segmentation by Type
The Global Lancet And Pen Needles Market has been segmented by Type into Insulin , Capillary Blood Sampling, Hormones , Glucose Like Peptide, and Skin Testing.
The Global Lancet and Pen Needles Market is a dynamic sector within the healthcare industry, crucial for the management of various medical conditions, particularly diabetes. Segmented by type, this market encompasses a comprehensive range of products tailored to diverse medical needs. Insulin needles play a pivotal role in the daily lives of millions of individuals managing diabetes, facilitating the administration of insulin to regulate blood sugar levels effectively. Capillary blood sampling needles are essential for routine blood glucose monitoring, providing accurate data for diabetic patients and healthcare professionals to make informed decisions about treatment and management strategies.
The market includes hormone needles, glucose-like peptide needles, and skin testing needles, each serving specific diagnostic and therapeutic purposes. Hormone needles are utilized in hormone therapy treatments, while glucose-like peptide needles aid in the management of diabetes by delivering medications that help control blood sugar levels. Skin testing needles are indispensable for allergy testing and other diagnostic procedures, contributing to the comprehensive nature of the lancet and pen needles market. This segmentation underscores the market's adaptability and responsiveness to the diverse needs of patients and healthcare providers worldwide, driving innovation and advancement in medical technology.
The segmentation of the Global Lancet and Pen Needles Market by type reflects the breadth and depth of its offerings, catering to a wide range of medical requirements. From insulin administration to blood glucose monitoring and diagnostic testing, these specialized needles play a critical role in supporting patient care and disease management. As advancements in medical technology continue to evolve and the prevalence of chronic conditions like diabetes rises globally, the demand for lancet and pen needles is expected to escalate, presenting significant opportunities for growth and innovation in the healthcare sector.
Global Lancet And Pen Needles Market, Segmentation by End User
The Global Lancet And Pen Needles Market has been segmented by End User into Hospitals & Clinics, Diagnostic Centers & Medical Institutions, Home Care & Home Diagnostics, and Research & Academic Laboratories.
The segmentation of the Global Lancet and Pen Needles Market by end users highlights the diverse settings where these essential medical devices are utilized. Hospitals and clinics serve as primary points of care for patients requiring lancet and pen needles for various medical procedures. These facilities cater to a wide range of healthcare needs, from routine blood glucose monitoring to more complex diagnostic tests and treatment regimens. Lancet and pen needles play a crucial role in facilitating accurate diagnosis and effective management of conditions such as diabetes, ensuring optimal patient outcomes within hospital and clinic settings.
Diagnostic centers and medical institutions rely on lancet and pen needles for a multitude of diagnostic tests and procedures. These facilities are equipped with advanced medical technologies and expertise, utilizing lancet and pen needles to conduct blood tests, hormone assays, and skin sensitivity assessments, among others. The availability of high-quality lancet and pen needles in diagnostic centers and medical institutions contributes to the accuracy and reliability of diagnostic results, supporting timely interventions and treatment decisions for patients across diverse healthcare settings.
The rise of home care and home diagnostics has transformed the landscape of healthcare delivery, empowering individuals to manage their health conditions from the comfort of their homes. Lancet and pen needles are integral components of home care and home diagnostics, enabling patients to perform self-monitoring of blood glucose levels, administer insulin injections, and conduct other diagnostic tests as prescribed by their healthcare providers. The accessibility and convenience offered by home care and home diagnostics contribute to improved patient adherence to treatment regimens and better disease management outcomes. Moreover, lancet and pen needles are utilized in research and academic laboratories for experimental studies and medical research, driving innovation and advancement in the field of healthcare.
Global Lancet And Pen Needles Market, Segmentation by Length
The Global Lancet And Pen Needles Market has been segmented by Length into 4mm, 5mm, 6mm, 8mm, 10mm and 12mm.
The 4mm length is one of the most commonly used needle lengths, especially for individuals with thinner skin, including children or elderly patients. These shorter needles are preferred for more comfortable, less invasive blood collection and insulin injection procedures. The growing preference for less painful injections, combined with increasing awareness about patient comfort, has led to a rise in the demand for 4mm lancets and pen needles, particularly in homecare settings.
The 5mm length is another popular option, offering a balance between ease of use and minimal discomfort. It is commonly used for both adults and children, as it provides a deeper penetration compared to the 4mm length, while still maintaining patient comfort. This needle length is often chosen in settings where frequent blood collection or insulin administration is required, particularly for patients with diabetes who are looking for efficient yet painless options.
The 6mm length is typically used for individuals with average skin thickness, offering a deeper penetration compared to shorter needles. This length is widely used for insulin injections in diabetic patients who require a greater level of penetration for optimal delivery of medication. The 6mm needles are also preferred in clinical settings and are commonly used in hospital and clinic-based diabetes management programs.
The 8mm length needles are generally used by individuals with thicker skin or those requiring a deeper injection for specific treatments. This length is commonly utilized in patients with obesity or those with more robust skin layers. The longer needle length ensures proper medication delivery, particularly for patients who may require insulin injections deeper into the subcutaneous tissue. While less common for everyday insulin use, 8mm needles are often found in hospitals and clinics for more intensive therapeutic applications.
The 10mm and 12mm lengths are typically used for more invasive procedures or in cases where deeper subcutaneous injections are necessary. These longer needles are less commonly used for insulin administration but may be preferred for certain clinical applications or blood draws requiring deeper penetration. Although they are less common in the homecare market, they still play a crucial role in specialized medical settings where specific therapeutic needs arise.
Overall, the segmentation of the market by needle length addresses varying patient needs, with shorter lengths focusing on comfort and convenience, while longer lengths serve more specific therapeutic purposes. As the market grows, the preference for shorter, more comfortable needles is expected to continue dominating, particularly in the diabetes management sector.
Global Lancet And Pen Needles Market, Segmentation by Therapy
The Global Lancet And Pen Needles Market has been segmented by Therapy into Insulin, GLP-1, Growth, Hormone Therapy, Glucose Like Peptide (GLP) and Skin Testing.
The Insulin therapy segment dominates the market, as lancets and pen needles are most commonly used for insulin administration in diabetic patients. Insulin therapy is essential for managing blood glucose levels in people with Type 1 and Type 2 diabetes, leading to a high demand for lancets and pen needles. These devices are designed for daily self-injections, with a preference for user-friendly, minimally painful options, ensuring the patient's adherence to their treatment plan.
The GLP-1 therapy segment has gained significant traction due to the rising use of glucagon-like peptide-1 receptor agonists for diabetes management and weight loss treatments. GLP-1 therapies have become popular in managing Type 2 diabetes, as they not only help regulate blood sugar levels but also promote weight loss. The growing adoption of injectable GLP-1 medications has led to a rise in demand for pen needles and lancets suitable for this therapy, especially for patients who require frequent injections.
The Growth Hormone Therapy segment caters to patients, particularly children, with growth deficiencies, where injections of growth hormones are required to stimulate growth. Lancets and pen needles used in growth hormone therapy must be precise and designed for frequent use to ensure effective treatment. This segment is growing as more awareness about pediatric growth hormone deficiencies increases, along with advances in biotechnology that have expanded the availability of growth hormone treatments.
The Glucose-Like Peptide (GLP) therapy segment focuses on medications that mimic the effects of natural hormones to help regulate blood sugar. Like GLP-1, GLP therapies are gaining popularity in the treatment of Type 2 diabetes due to their efficacy in controlling blood sugar levels and supporting weight management. With the expanding therapeutic options in the GLP family, there is an increasing need for efficient delivery systems, boosting demand for lancets and pen needles suited for these therapies.
The Skin Testing segment includes devices used in allergy testing and other diagnostic procedures. Lancets used for skin testing are typically designed for one-time use, offering minimal discomfort while collecting small blood samples for testing. As the frequency of allergy and disease testing increases, the market for skin testing devices continues to grow, with demand for high-quality lancets and pen needles suited to the specific needs of diagnostic tests.
The segmentation by therapy reflects the broadening application of lancet and pen needles across various therapeutic areas, with insulin therapy remaining the largest contributor while newer therapies such as GLP-1 and growth hormone treatments also showing rapid market expansion.
Global Lancet And Pen Needles Market, Segmentation by Gauge
The Global Lancet And Pen Needles Market has been segmented by Gauge into 17/18G, 21G, 23G, 25G, 28G and 30G.
The 17/18G segment refers to needles with a relatively large diameter, commonly used for blood collection or for patients who require a faster blood flow. While these gauges are less commonly used for routine injections, they are preferred in certain medical procedures that require more substantial blood withdrawal or in settings where rapid access is needed. These thicker needles are less comfortable but offer improved flow for specific applications, making them critical in specific therapeutic or diagnostic settings.
The 21G and 23G needles are more frequently used for injections, including insulin administration and other treatments that require precise, controlled delivery. These sizes strike a balance between comfort and performance, offering moderate thickness that allows for sufficient flow without being as painful as larger gauges. The 21G is used in cases where a slightly thicker needle is necessary, such as for larger volume injections, while the 23G is often favored for its versatility and ease of use across various therapies, making it one of the more common choices in both healthcare and homecare settings.
The 25G needle is one of the most widely used gauges in the market, particularly in pen needles for insulin delivery. This gauge offers a good balance between needle thickness and comfort for patients who require daily injections, such as those with diabetes. The 25G needles are ideal for subcutaneous injections, providing less pain and reducing the risk of complications. Their popularity in the diabetes community has contributed to the segment's large market share, particularly in homecare settings where ease of use and patient compliance are key.
The 28G and 30G segments consist of very fine needles, which are ideal for use in patients who need frequent, less painful injections. These smaller gauge needles are particularly popular in diabetes care, where daily insulin injections require precision and minimal discomfort. The 30G needle, in particular, is one of the smallest available, offering high comfort for those with needle phobia or those who need injections in sensitive areas, such as pediatric patients or those with fragile skin. These fine gauges are preferred for both insulin and other subcutaneous therapies where minimal trauma to the skin is essential.
Overall, the segmentation of the market by gauge reflects the varying needs across different therapeutic areas, with finer gauges being preferred for comfort in chronic treatments like diabetes care, while larger gauges find their application in more intensive or rapid medical procedures. The broad range of gauges ensures that pen needles and lancets can be tailored to the specific requirements of different patients, treatments, and clinical settings.
Global Lancet And Pen Needles Market, Segmentation by Geography
In this report, the Global Lancet And Pen Needles Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Lancet And Pen Needles Market Share (%), by Geographical Region, 2024
The Global Lancet and Pen Needles Market, geographical segmentation into five regions provides valuable insights into regional trends, preferences, and market dynamics. North America, comprising the United States and Canada, stands as a prominent market for lancet and pen needles, driven by factors such as the high prevalence of diabetes, advanced healthcare infrastructure, and strong emphasis on disease management and prevention. The region's robust regulatory framework and technological advancements further contribute to the widespread adoption of lancet and pen needle products, making it a significant revenue generator within the global market.
Europe, encompassing countries like Germany, the United Kingdom, and France, represents another key region in the Lancet and Pen Needles Market. With a growing aging population and increasing incidence of diabetes and other chronic conditions, Europe exhibits substantial demand for lancet and pen needle products across various healthcare settings. Moreover, favorable reimbursement policies and initiatives aimed at promoting diabetes management and awareness drive market growth in this region. Additionally, the presence of leading manufacturers and research institutions fosters innovation and product development, further enhancing the market landscape in Europe.
The Asia Pacific region, including countries such as China, Japan, and India, presents significant growth opportunities for the Lancet and Pen Needles Market. Rapid urbanization, changing lifestyles, and increasing healthcare expenditures contribute to the rising prevalence of diabetes and other chronic diseases in this region. As a result, there is a growing demand for lancet and pen needle products to support disease management and diagnostic testing. Furthermore, initiatives aimed at improving healthcare infrastructure, coupled with expanding access to healthcare services, fuel market expansion across Asia Pacific. The Middle East and Africa, along with Latin America, also play pivotal roles in the Lancet and Pen Needles Market, driven by evolving healthcare landscapes, rising healthcare investments, and efforts to enhance disease management and healthcare accessibility. Overall, geographical segmentation provides a comprehensive understanding of the global market dynamics and opportunities for stakeholders across different regions.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Lancet And Pen Needles Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Diabetes Prevalence
- Technological Advancements
-
Growing Demand for Home Healthcare - The growing demand for home healthcare reflects a broader trend towards patient-centric care and the empowerment of individuals in managing their health conditions. Home healthcare encompasses a range of medical services and devices that can be delivered or administered in a patient's home environment, including lancet and pen needles for conditions such as diabetes.
One key driver of the growing demand for home healthcare is the aging population, which is leading to an increased prevalence of chronic diseases such as diabetes. As individuals age, they may prefer the comfort and convenience of receiving medical care at home rather than in a clinical setting. Home healthcare allows patients to maintain a sense of independence and autonomy while receiving the necessary support for managing their health conditions.
Advancements in technology have also played a significant role in driving the demand for home healthcare. The development of portable medical devices, including lancet and pen needles, enables patients to monitor their health parameters more easily and accurately from home. These devices are often designed to be user-friendly, allowing patients to perform self-monitoring and self-administration of medications with minimal assistance.
Restraints:
- Regulatory Challenges
- Limited Access to Healthcare
-
High Cost of Advanced Devices - The high cost of advanced devices presents a significant challenge in the Lancet and Pen Needles Market, particularly for patients and healthcare systems facing budget constraints. Advanced lancet and pen needle devices often incorporate cutting-edge technologies such as automatic needle insertion, adjustable penetration depths, and integrated blood glucose monitoring systems, which contribute to their higher price points. This cost barrier can limit access to these devices for patients who may benefit from their advanced features, potentially impacting their ability to effectively manage their health conditions.
The high cost of advanced devices poses financial challenges for healthcare systems and payers, particularly in regions with limited healthcare budgets or reimbursement constraints. Healthcare providers may face difficult decisions when allocating resources, potentially prioritizing lower-cost alternatives over advanced devices, even if they offer superior performance or additional benefits for patients. This cost consideration can influence purchasing decisions and reimbursement policies, shaping the availability and accessibility of advanced lancet and pen needle devices in healthcare settings.
However, despite the challenges posed by the high cost of advanced devices, there are opportunities for innovation and cost optimization in the Lancet and Pen Needles Market. Manufacturers may explore strategies such as product redesign, materials optimization, and manufacturing process improvements to reduce production costs and make advanced devices more affordable without compromising quality or performance. Additionally, initiatives aimed at increasing healthcare coverage and reimbursement for advanced devices can help improve affordability and access for patients, ensuring that they can benefit from the latest advancements in lancet and pen needle technology. Ultimately, addressing the high cost of advanced devices requires collaboration between stakeholders across the healthcare ecosystem to balance innovation with affordability and improve patient outcomes.
Opportunities:
- Markets Expansions
- Rising Adoption of Self-Monitoring Devices
-
Focus on Product Innovation and Customization - The emphasis on product innovation and customization is driving significant transformation within the Lancet and Pen Needles Market, as manufacturers strive to meet the evolving needs and preferences of patients and healthcare professionals. Innovation in lancet and pen needle design, materials, and functionality is aimed at enhancing user experience, improving safety and efficacy, and optimizing patient outcomes. Customization allows for tailoring devices to specific patient populations, clinical settings, and healthcare workflows, maximizing their utility and value across diverse applications.
One key area of innovation in lancet and pen needle products is the integration of advanced technologies, such as Bluetooth connectivity, smartphone apps, and cloud-based data management platforms. These features enable real-time data monitoring, analysis, and sharing, empowering patients and healthcare providers with actionable insights into blood glucose levels, insulin dosing, and treatment adherence. By leveraging digital health solutions, manufacturers can enhance patient engagement, promote self-management, and facilitate remote monitoring and telehealth consultations, thereby improving overall diabetes care and outcomes.
The focus on product innovation and customization is driving differentiation and competitive advantage in the Lancet and Pen Needles Market, fostering continuous improvement and advancement in medical device technology. By embracing innovation and customization, manufacturers can address unmet clinical needs, enhance patient experiences, and contribute to better healthcare outcomes for individuals managing diabetes and other chronic conditions.
Competitive Landscape Analysis
Key players in Global Lancet And Pen Needles Market include:
- B. Braun Melsungen AG
- Terumo Corporation
- Becton Dickinson
- Sanofi
- F. Hoffmann-La Roche AG
- Bayer AG
- Novo Nordisk A S
- Eli Lilly And Company
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Length
- Market Snapshot, By Therapy
- Market Snapshot, By Gauge
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Lancet And Pen Needles Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Diabetes Prevalence
- Technological Advancements
- Growing Demand for Home Healthcare
- Restraints
- Regulatory Challenges
- Limited Access to Healthcare
- High Cost of Advanced Devices
- Opportunities
- Markets Expansions
- Rising Adoption of Self-Monitoring Devices
- Focus on Product Innovation and Customization
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Lancet And Pen Needles Market, By Type, 2021 - 2031 (USD Million)
- Insulin
- Capillary Blood Sampling
- Hormones
- Glucose Like Peptide
- Skin Testing
- Global Lancet And Pen Needles Market, By End User, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers & Medical Institutions
- Home Care & Home Diagnostics
- Research & Academic Laboratories
- Global Lancet And Pen Needles Market, By Length, 2021 - 2031 (USD Million)
- 4mm
- 5mm
- 6mm
- 8mm
- 10mm
- 12mm
- Global Lancet And Pen Needles Market, By Therapy, 2021 - 2031 (USD Million)
- Insulin
- GLP-1
- Growth
- Hormone Therapy
- Glucose Like Peptide (GLP)
- Skin Testing
- Global Lancet And Pen Needles Market, By Gauge, 2021 - 2031 (USD Million)
- 17/18G
- 21G
- 23G
- 25G
- 28G
- 30G
- Global Lancet And Pen Needles Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Lancet And Pen Needles Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- B. Braun Melsungen AG
- Terumo Corporation
- Becton Dickinson
- Sanofi
- F. Hoffmann-La Roche AG
- Bayer AG
- Novo Nordisk A S
- Eli Lilly And Company
- Company Profiles
- Analyst Views
- Future Outlook of the Market